piritrexim has been researched along with Leukopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawshaw, A; de Vries, EG; Dennis, I; Dobbs, HJ; Gietema, JA; Mulder, NH; Scott, JE; Sleijfer, DT; Willemse, PH; Workman, P | 1 |
| Clendeninn, NJ; Collier, M; Feun, LG; Gonzalez, R; Hanlon, J; Robinson, WA; Savaraj, N | 1 |
2 trial(s) available for piritrexim and Leukopenia
| Article | Year |
|---|---|
A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Neoplasm Metastasis; Pyrimidines; Thrombocytopenia | 1993 |
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Pyrimidines; Thrombocytopenia | 1991 |